
|Videos|September 19, 2016
When Should Patients Switch from Statins to PCSK9 Inhibitors?
Author(s)Lauren Santye, Assistant Editor
Mark Tesell, PharmD, BCPS, clinical consultant pharmacist at UMass Medical School, discusses the treatment switch from statins to PCSK9 inhibitors in patients with high cholesterol.
Advertisement
Mark Tesell, PharmD, BCPS, clinical consultant pharmacist at UMass Medical School, discusses the treatment switch from statins to PCSK9 inhibitors in patients with high cholesterol.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Guiding Patients With Sickle Cell Disease Through the Transformative Era of Gene Therapy
2
New Data Highlights Pharmacists’ Expanding Roles in Hematologic Malignancies
3
FDA, ASH Experts Review Newly Approved Therapies in Hemophilia
4
Pharmacist Strategies for Managing Comorbid Depression and Diabetes
5
















































































































































































































